Loading company…
Riskpilot
← Back to search
Sign in
Get full access
VitaMed ApS
APS
Active
CVR 43890514
Sct Knuds Alle 23
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2023
6 employees
Vitamed.dk
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 1,3M
-38% vs 2024
EBITDA margin
-27.0%
-130% vs 2024
Equity ratio
29.8%
Financial strength
Net profit 2025
DKK -339K
-140% vs 2024
EBITDA — year on year
DKK millions
0M
0M
1M
1M
1M
1M
2024
0M
-100%
2025
Key figures
Annual report 2025
Revenue
DKK 1,3M
-38%
EBITDA
DKK -340K
-130%
Net profit
DKK -339K
-140%
Total assets
DKK 1,9M
+13%
Equity
DKK 558K
-38%
Employees
6
—
Company information
Legal name
VitaMed ApS
CVR number
43890514
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
3. marts 2023
Share capital
DKK 40.000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktøren.
Company purpose
Selskabets formål er at drive handel samt anden virksomhed forbundet hermed.
Contact
Address
Sct Knuds Alle 23
Phone
+4555225272
Email
info@vitamed.dk
Website
Vitamed.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Hjørring
All Denmark companies
Revenue
DKK millions
0M
1M
1M
2M
2M
2M
2024
1M
2025
EBITDA
DKK millions
0M
0M
1M
1M
1M
1M
2024
0M
2025
Income statement
DKK thousands
Item
2024
2025
Revenue
2.017
1.255
Staff expenses
-886
-1.595
EBITDA
1.131
-340
Depreciation & amort.
-15
-15
EBIT
1.116
-355
Net financials
-6
-20
Profit before tax
1.110
-375
Tax
253
-36
Net profit
857
-339
Balance sheet
DKK thousands
Item
2024
2025
Total assets
1.658
1.872
Equity
897
558
Long-term debt
250
0
Short-term debt
508
1.314
Total debt
757
1.314
Financial ratios
5-year trend
EBITDA margin
-27.0%
This company
15.8%
Market median
-271% vs market
2024
2025
Equity ratio
29.8%
This company
38.2%
Market median
-22% vs market
2024
2025
Return on equity
-60.7%
This company
18.4%
Market median
-430% vs market
2024
2025
Net profit margin
-27.0%
This company
8.1%
Market median
-433% vs market
2024
2025
Asset turnover
0.67×
This company
1.12×
Market median
-40% vs market
2024
2025
Debt / equity
2.35×
This company
0.62×
Market median
-279% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2024-09-01 – 2025-08-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-03-03 – 2024-08-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Age
Other directorships
KH
Kim Hang Nguyen
Management
Management
2025
—
—
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
VitaMed Holding ApS
Company
100.0%
100.0%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
VitaMed Holding ApS
VitaMed ApS
(this company)
Board network connections
Board members of VitaMed ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Kim Hang Nguyen
Management
0 companies